Form 4: Guardant Health Exec Acquires Shares

Sentiment:

Statement of Changes in Beneficial Ownership


Darya Chudova, Chief Technology Officer at Guardant Health, Inc., reported transactions involving the acquisition of common stock and restricted stock units.

Summary

  • Darya Chudova, Chief Technology Officer at Guardant Health, Inc., acquired a total of 11,329 shares of common stock on April 1, 2026.
  • These acquisitions were primarily through the vesting of restricted stock units (RSUs) granted on various dates between November 2022 and March 2025.
  • A portion of the acquired shares (7,005) were retained by the company to cover tax withholding obligations.
  • Following these transactions, Chudova beneficially owns 70,376 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions related to equity vesting and tax withholding, without indicating significant new strategic direction or financial performance.

Positives

  • The Chief Technology Officer has acquired additional shares, indicating continued commitment to the company.
  • Vesting of restricted stock units suggests that performance or time-based conditions have been met.
  • The company is managing tax withholding obligations efficiently by retaining a portion of the vested shares.

Negatives

  • The filing details the retention of shares for tax withholding, which reduces the immediate net shares received by the executive.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it pertains to past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive stock ownership and activity. This filing reflects typical executive compensation and equity vesting events within the biotechnology and diagnostics sector.

Stakeholder Impact

  • Shareholders: Increased transparency into executive stock holdings and potential alignment of executive interests with shareholders.
  • Employees: Vesting of RSUs can be a positive indicator for employees who also hold equity, reflecting company performance or tenure.
  • Management: The transaction reflects the standard compensation and equity management practices for senior executives.

Key Dates

DateDescription
04/01/2026Transaction Date for acquisition of common stock and vesting of RSUs.
04/02/2026Date of signature for the filing.

Keywords

Guardant Health, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Executive Compensation, Beneficial Ownership, Securities Exchange Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.